| Role of Active Deresuscitation After Resuscitation: (NCT06326112) | Unity Health Toronto | 2024-05-01 |
| A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis (NCT06436183) | Apollo Therapeutics Ltd | 2024-05-01 |
| Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT05773079) | Nanfang Hospital, Southern Medical University | 2024-05-01 |
| Canagliflozin in Advanced Renal Disease With MRI Endpoints (NCT06182839) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2024-05-01 |
| A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer (NCT06079346) | Oncotelic Inc. | 2024-05-01 |
| SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases (NCT06361979) | Huihua Xiong | 2024-05-01 |
| Propionic Acid in Multiple Sclerosis (NCT06402487) | Salzburger Landeskliniken | 2024-05-01 |
| Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin (NCT06406426) | Fudan University | 2024-05-01 |
| Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer (NCT06379659) | Isfahan University of Medical Sciences | 2024-05-01 |
| High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib (NCT06394674) | Changhai Hospital | 2024-05-01 |
| PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study) (NCT06345599) | Second Affiliated Hospital of Soochow University | 2024-05-01 |
| To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer (NCT06385847) | The First Affiliated Hospital of Xiamen University | 2024-05-01 |
| Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC (NCT06379087) | Ji Yongling | 2024-05-01 |
| A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer (NCT06362096) | Huihua Xiong | 2024-05-01 |
| Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy (NCT06375915) | Francesco De Cobelli | 2024-05-01 |
| Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma (NCT06405061) | Tianjin Medical University Cancer Institute and Hospital | 2024-05-01 |
| FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery (NCT06684795) | Rigshospitalet, Denmark | 2024-05-01 |
| Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer (NCT06421376) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-05-01 |
| Study Evaluating Patients With Cystinuria (NCT04137978) | Advicenne Pharma | 2024-05-01 |
| Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases (NCT06440954) | Hunan Province Tumor Hospital | 2024-05-01 |
| Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma. (NCT06324994) | Dalian Medical University | 2024-05-01 |
| The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT (NCT06362967) | Anhui Provincial Hospital | 2024-05-01 |
| Oral Calcium Supplementation in Labor (NCT07056062) | Arrowhead Regional Medical Center | 2024-04-30 |
| Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer (NCT06391008) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-04-30 |
| Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program (NCT06265285) | Mayo Clinic | 2024-04-30 |
| The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study (NCT06958627) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-04-30 |
| Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma (NCT06242249) | Shahid Beheshti University of Medical Sciences | 2024-04-30 |
| Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer (NCT07635342) | Hebei Medical University Fourth Hospital | 2024-04-30 |
| Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer (NCT06349967) | West China Hospital | 2024-04-30 |
| HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure (NCT06375317) | Yehua Shen | 2024-04-30 |
| Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess (NCT06394128) | First People's Hospital of Hangzhou | 2024-04-30 |
| Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy (NCT06268327) | Assiut University | 2024-04-30 |
| Newly Emerging Immunotherapy for Pancreatic Cancer Treatment (NCT06370754) | Fudan University | 2024-04-30 |
| Biomarkers to Detect Endocrine Therapy Resistance (NCT06067503) | University of Wisconsin, Madison | 2024-04-30 |
| Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases (NCT06374888) | Convalife (Shanghai) Co., Ltd. | 2024-04-30 |
| Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion (NCT06350981) | Foundation for Orthopaedic Research and Education | 2024-04-30 |
| The Effect of Mankai on Glycemic Control Among Patients With T2D (NCT06416475) | Ben-Gurion University of the Negev | 2024-04-30 |
| TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. (NCT06353360) | Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | 2024-04-30 |
| PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC (NCT06396637) | Sun Yat-sen University | 2024-04-30 |
| A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma (NCT06464185) | Institute of Hematology & Blood Diseases Hospital, China | 2024-04-30 |
| Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy (NCT05953831) | Cardior Pharmaceuticals GmbH | 2024-04-30 |
| Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure (NCT06423599) | Jens D Hove, MD,PHD | 2024-04-30 |
| Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours. (NCT06304818) | Sinocelltech Ltd. | 2024-04-30 |
| S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP (NCT06188702) | Servier Bio-Innovation LLC | 2024-04-29 |
| A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer (NCT06394804) | Memorial Sloan Kettering Cancer Center | 2024-04-29 |
| A Study Evaluating APG777 in Atopic Dermatitis (NCT06395948) | Apogee Therapeutics, Inc. | 2024-04-29 |
| A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia (NCT06387420) | Akeso | 2024-04-29 |
| A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385925) | Tyligand Pharmaceuticals (Suzhou) Limited | 2024-04-29 |
| Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt (NCT06282458) | Veru Inc. | 2024-04-29 |
| Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma (NCT06461182) | Koo Foundation Sun Yat-Sen Cancer Center | 2024-04-29 |
| Pharmacologic Treatment Augmentation in Chronic Depression (NCT06410599) | University Hospital Tuebingen | 2024-04-29 |
| Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy (NCT06645509) | Dryox Health | 2024-04-29 |
| DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) (NCT06539182) | Dizal Pharmaceuticals | 2024-04-29 |
| To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer (NCT06389006) | RemeGen Co., Ltd. | 2024-04-29 |
| Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer (NCT06394661) | Henan Cancer Hospital | 2024-04-28 |
| A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis (NCT06194201) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-04-27 |
| Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum (NCT06040346) | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 2024-04-26 |
| Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. (NCT06385691) | Centre Leon Berard | 2024-04-26 |
| Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma (NCT06384248) | Letolab | 2024-04-26 |
| The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures (NCT05672368) | City of Hope Medical Center | 2024-04-26 |
| A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy (NCT05808764) | Hoffmann-La Roche | 2024-04-26 |
| A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC (NCT06383052) | Norroy Bioscience Co., LTD | 2024-04-26 |
| A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants (NCT06345339) | AbbVie | 2024-04-26 |
| Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma (NCT06298968) | Nanfang Hospital, Southern Medical University | 2024-04-26 |
| Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas (NCT06225999) | Institut de Recherches Internationales Servier | 2024-04-25 |
| A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors (NCT06248515) | Georgetown University | 2024-04-25 |
| Phase II Clinical Study of LTC004 in Patients With mCRC (NCT06384235) | Letolab | 2024-04-25 |
| Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics (NCT06194305) | University of Minnesota | 2024-04-25 |
| Evaluation of Effect of Platelet-Rich Fibrin on Orthodontic Tooth Movement: a Split Mouth Randomised Controlled Trial (NCT06634017) | Dow University of Health Sciences | 2024-04-25 |
| Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. (NCT06374901) | Xiangdong Cheng | 2024-04-25 |
| ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells (NCT06090864) | UNC Lineberger Comprehensive Cancer Center | 2024-04-25 |
| Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas (NCT05681195) | Baptist Health South Florida | 2024-04-25 |
| A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer (NCT06527300) | Zhejiang Wenda Pharma Technology LTD. | 2024-04-25 |
| Further MT for Antibiotic-Resistant Bacterial Colonization (NCT05835206) | Emory University | 2024-04-25 |
| Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma (NCT06340711) | Weill Medical College of Cornell University | 2024-04-25 |
| Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia (NCT06410859) | LKGS_277 | 2024-04-25 |
| Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors (NCT07434206) | South Egypt Cancer Institute | 2024-04-25 |
| Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL (NCT06393985) | The First Affiliated Hospital of Soochow University | 2024-04-25 |
| Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients with Benign Prostatic Hyperplasia-related Obstruction (NCT06212453) | Assistance Publique - Hôpitaux de Paris | 2024-04-24 |
| Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation (NCT06110572) | Vanderbilt-Ingram Cancer Center | 2024-04-24 |
| A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity (NCT06373146) | Eli Lilly and Company | 2024-04-24 |
| A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy (NCT06376942) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2024-04-24 |
| A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer (NCT06114511) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-04-24 |
| Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) (NCT05665361) | National Cancer Institute (NCI) | 2024-04-24 |
| Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC (NCT06718309) | First People's Hospital of Hangzhou | 2024-04-24 |
| Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation (NCT06130059) | University of Texas Southwestern Medical Center | 2024-04-24 |
| PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function (NCT06729853) | Shanton Pharma Pte. Ltd. | 2024-04-24 |
| Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF (NCT06331624) | GRI Bio Operations, Inc. | 2024-04-24 |
| Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (NCT06472388) | AC Camargo Cancer Center | 2024-04-24 |
| Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) (NCT06599918) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2024-04-23 |
| A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis (NCT06972888) | Accro Bioscience (Suzhou) Limited | 2024-04-23 |
| Semaglutide for Post-Smoking Cessation Weight Management (NCT06173778) | The University of Texas Health Science Center, Houston | 2024-04-23 |
| The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study (NCT06059664) | University of North Carolina, Chapel Hill | 2024-04-23 |
| Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM (NCT06503107) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-04-23 |
| A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC (NCT06439771) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-04-23 |
| Dimethyl Fumarate in Adrenomyeloneuropathy (NCT06513533) | Pujol, Aurora, M.D. | 2024-04-23 |
| Low Dose Bupivacaine Versus Prilocaine Regarding Hemodynamic Stability and Safety in Geriatrics (NCT06382220) | Fayoum University Hospital | 2024-04-23 |
| Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer (NCT06369610) | Mayo Clinic | 2024-04-22 |
| A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause (NCT06385795) | Noema Pharma AG | 2024-04-22 |
| A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients (NCT06322628) | Visirna Therapeutics HK Limited | 2024-04-22 |